WebinarsNew
Deep DiveNew
Explore Business Standard
The revenue stands at ₹2,820.47 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.30 per cent from ₹2,580.45 crore. This corresponds to a year-on-year *(YoY) growth of 24.26 per cent.
Operating Profit stands at ₹587.84 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.39 per cent from ₹532.50 crore. This corresponds to a year-on-year *(YoY) growth of 23.63 per cent.
PBDT stands at ₹555.52 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.43 per cent from ₹503.03 crore. This corresponds to a year-on-year *(YoY) growth of 24.54 per cent.
Profit Before Tax stands at ₹445.86 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.30 per cent from ₹393.52 crore. This corresponds to a year-on-year *(YoY) growth of 30.59 per cent.
Net Profit stands at ₹325.07 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.14 per cent from ₹292.49 crore. This represents a 29.32 per cent year-on-year *(YoY) growth for the same year.
| Category | Q2 FY26-27 | Q2 FY25-26 | Change % | FY25-26 | FY24-25 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 2,820.47 | 2,269.82 | 24.26 | 9,203.54 | 7,896.00 | 16.56 |
| Expenses | 2,232.63 | 1,794.34 | 24.43 | 7,370.34 | 6,432.00 | 14.59 |
| Other Income | 3.25 | 3.12 | 4.17 | 12.66 | 67.26 | -81.18 |
| Operating Profit | 587.84 | 475.48 | 23.63 | 1,845.86 | 1,531.26 | 20.55 |
| Depreciation | 109.66 | 104.64 | 4.80 | 415.05 | 384.13 | 8.05 |
| Interest | 35.58 | 32.54 | 9.34 | 143.67 | 175.78 | -18.27 |
| Profit Before Tax | 445.86 | 341.42 | 30.59 | 1,287.14 | 971.35 | 32.51 |
| Tax | 120.79 | 90.05 | 34.14 | 392.56 | 292.16 | 34.36 |
| Net Profit | 325.07 | 251.37 | 29.32 | 941.27 | 707.47 | 33.05 |
| Category | Q2 FY26-27 | Q2 FY25-26 | Change % | FY25-26 | FY24-25 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 1,667.98 | 1,260.60 | 32.32 | 5,243.19 | 4,381.92 | 19.66 |
| Expenses | 1,271.72 | 1,036.01 | 22.75 | 4,143.51 | 3,735.09 | 10.93 |
| Other Income | 33.54 | 22.75 | 47.43 | 209.52 | 118.81 | 76.35 |
| Operating Profit | 1,358.25 | 1,016.59 | 33.61 | 1,309.20 | 765.64 | 70.99 |
| Depreciation | 65.01 | 61.74 | 5.30 | 246.73 | 224.97 | 9.67 |
| Interest | 32.42 | 27.71 | 17.00 | 118.27 | 112.96 | 4.70 |
| Profit Before Tax | 332.38 | 157.89 | 110.51 | 944.19 | 427.71 | 120.75 |
| Tax | 83.95 | 40.27 | 108.47 | 233.74 | 112.71 | 107.38 |
| Net Profit | 248.43 | 117.62 | 111.21 | 732.96 | 317.13 | 131.12 |
| Category | Q2 FY26-27 | Q1 FY26-27 | Change % |
|---|---|---|---|
| Total Revenue | 2,820.47 | 2,580.45 | 9.30 |
| Expenses | 2,232.63 | 2,047.95 | 9.02 |
| Other Income | 3.25 | 2.07 | 57.00 |
| Operating Profit | 587.84 | 532.50 | 10.39 |
| Depreciation | 109.66 | 109.51 | 0.14 |
| Interest | 35.58 | 31.54 | 12.81 |
| Profit Before Tax | 445.86 | 393.52 | 13.30 |
| Tax | 120.79 | 101.03 | 19.56 |
| Net Profit | 325.07 | 292.49 | 11.14 |
| Category | Q2 FY26-27 | Q1 FY26-27 | Change % |
|---|---|---|---|
| Total Revenue | 1,667.98 | 1,450.93 | 14.96 |
| Expenses | 1,271.72 | 1,111.35 | 14.43 |
| Other Income | 33.54 | 25.03 | 34.00 |
| Operating Profit | 1,358.25 | 1,208.29 | 12.41 |
| Depreciation | 65.01 | 63.17 | 2.91 |
| Interest | 32.42 | 32.78 | -1.10 |
| Profit Before Tax | 332.38 | 268.68 | 23.71 |
| Tax | 83.95 | 68.57 | 22.43 |
| Net Profit | 248.43 | 200.11 | 24.15 |
Data not available.
| Company | 1 Day | 1 Week | 1 Month | 3 Months | 6 Month | 1 Year |
|---|---|---|---|---|---|---|
| Emcure Pharma | 0.86% | 0.65% | 34.08% | 26.18% | 34.46% | 73.59% |
| Anthem Bioscienc | 2.54% | 0.78% | 16.85% | 7.75% | 22.08% | 47.85% |
| Ipca Labs. | 0.48% | -0.04% | -2.65% | -2.33% | 13.33% | 29.24% |
| Glaxosmi. Pharma | 3.35% | 2.49% | 10.20% | -6.37% | 16.99% | 8.74% |
| Ajanta Pharma | 0.05% | -2.51% | 0.47% | -10.05% | 4.02% | 31.76% |
| Sai Life | 0.09% | -0.45% | 28.50% | 23.04% | 57.50% | 108.02% |
| Wockhardt | 7.61% | 9.08% | 16.65% | 15.95% | 36.57% | 66.66% |
No More Data
More